CAE.TO | CAE Inc. Annual & Quarterly Balance Sheets

Annual Balance Sheets

(In CAD)

Breakdown	2024	2023	2022	2021	2020	2019
Total Assets	9.83 Billion	10.43 Billion	9.57 Billion	8.74 Billion	8.48 Billion	7.16 Billion
Total Current Assets	2 Billion	2.23 Billion	2.14 Billion	3.37 Billion	2.8 Billion	2.11 Billion
Cash And Short Term Investments	160.1 Million	217.6 Million	346.1 Million	926.1 Million	946.5 Million	446.1 Million
Cash and Cash Equivalents	160.1 Million	217.6 Million	346.1 Million	926.1 Million	946.5 Million	446.1 Million
Short Term Investments	-	-	-	-	-	-
Net Receivables	1.19 Billion	1.35 Billion	1.19 Billion	1.02 Billion	1.16 Billion	1.05 Billion
Inventory	573.6 Million	583.4 Million	519.8 Million	647.8 Million	616.2 Million	537 Million
Other Current Assets	75.2 Million	76.2 Million	84.3 Million	784.4 Million	80.1 Million	76.7 Million
Total Non-Current Assets	7.82 Billion	8.2 Billion	7.43 Billion	5.36 Billion	5.67 Billion	5.05 Billion
Net PPE	3.09 Billion	2.81 Billion	2.5 Billion	2.27 Billion	2.54 Billion	2.14 Billion
Good Will And Intangible Assets	3.27 Billion	4.05 Billion	3.79 Billion	2.05 Billion	2.05 Billion	2.02 Billion
Good Will	1.97 Billion	2.66 Billion	2.46 Billion	1.17 Billion	1.08 Billion	1.06 Billion
Intangible Assets	1.3 Billion	1.38 Billion	1.33 Billion	882.6 Million	971.2 Million	960.2 Million
Long-Term Investments	832 Million	530.7 Million	454 Million	422.2 Million	460.6 Million	312.1 Million
Tax Assets	233.3 Million	125.1 Million	117.4 Million	104.9 Million	84.5 Million	71 Million
Other Non Current Assets	399 Million	680.9 Million	560.2 Million	509 Million	523.5 Million	492.3 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	5.53 Billion	5.84 Billion	5.49 Billion	5.53 Billion	5.9 Billion	4.75 Billion
Total Current Liabilities	2.35 Billion	2.24 Billion	2.09 Billion	2.63 Billion	2.06 Billion	1.88 Billion
Account Payables	561.7 Million	1.03 Billion	436.2 Million	945.6 Million	539.7 Million	458.9 Million
Tax Payables	31.1 Million	21.1 Million	22.7 Million	16.2 Million	26.4 Million	25.7 Million
Short Term Debt	319.8 Million	214.6 Million	241.8 Million	216.3 Million	206.2 Million	264.1 Million
Deferred Revenue	911.7 Million	905.7 Million	804.5 Million	674.7 Million	761.4 Million	681.8 Million
Other Current Liabilities	565.2 Million	89.7 Million	608.7 Million	796.7 Million	555 Million	484.7 Million
Total Non Current Liabilities	3.17 Billion	3.6 Billion	3.4 Billion	2.9 Billion	3.84 Billion	2.86 Billion
Long-Term Debt	2.34 Billion	3.03 Billion	2.8 Billion	2.13 Billion	3.1 Billion	2.06 Billion
Deferred Revenue Non Current	99.8 Million	94 Million	130.3 Million	108.6 Million	104.7 Million	143.2 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	693.6 Million	342.1 Million	372.6 Million	535 Million	481.7 Million	511.6 Million
Other Liabilities	-	-	-	-	-	-
Total Equity	4.3 Billion	4.58 Billion	4.08 Billion	3.21 Billion	2.57 Billion	2.41 Billion
Stock Holders Equity	4.22 Billion	4.5 Billion	4 Billion	3.14 Billion	2.48 Billion	2.33 Billion
Common Stock	2.25 Billion	2.24 Billion	2.22 Billion	1.51 Billion	679.5 Million	649.6 Million
Retained Earnings	1.76 Billion	2.05 Billion	1.77 Billion	1.54 Billion	1.59 Billion	1.45 Billion
Accumulated other comprehensive income	154 Million	167.2 Million	-31.2 Million	58.1 Million	193.2 Million	199 Million
Common Stock Equity	4.22 Billion	4.5 Billion	4 Billion	3.14 Billion	2.48 Billion	2.33 Billion
Capital Lease Obligation	496.7 Million	455.9 Million	395 Million	347.2 Million	487.8 Million	62.8 Million
Total Investments	832 Million	530.7 Million	454 Million	422.2 Million	460.6 Million	312.1 Million
Total Debt	3.15 Billion	3.25 Billion	3.04 Billion	2.35 Billion	3.31 Billion	2.32 Billion
Net Debt	2.99 Billion	3.03 Billion	2.7 Billion	1.42 Billion	2.36 Billion	1.88 Billion

Breakdown	2024 Q1	2023 Q4	2023 FY	2023 Q3	2023 Q2	2023 Q1
Total Assets	10.05 Billion	9.83 Billion	9.83 Billion	10.47 Billion	10.56 Billion	10.32 Billion
Total Current Assets	2.05 Billion	2 Billion	2 Billion	2.41 Billion	2.28 Billion	2.21 Billion
Cash And Short Term Investments	143.2 Million	160.1 Million	160.1 Million	124.5 Million	181.5 Million	152.8 Million
Cash and Cash Equivalents	143.2 Million	160.1 Million	160.1 Million	124.5 Million	181.5 Million	152.8 Million
Short Term Investments	-	-	-	-	-	-1.00
Net Receivables	1.18 Billion	1.19 Billion	1.19 Billion	1.26 Billion	1.35 Billion	1.31 Billion
Inventory	634.8 Million	573.6 Million	573.6 Million	601 Million	655.8 Million	651.5 Million
Other Current Assets	96.2 Million	75.2 Million	75.2 Million	420.7 Million	89.8 Million	94.3 Million
Total Non-Current Assets	8 Billion	7.82 Billion	7.82 Billion	8.06 Billion	8.28 Billion	8.1 Billion
Net PPE	3.19 Billion	3.09 Billion	3.09 Billion	2.9 Billion	2.88 Billion	2.8 Billion
Good Will And Intangible Assets	3.29 Billion	3.27 Billion	3.27 Billion	3.83 Billion	4.04 Billion	3.98 Billion
Good Will	-	1.97 Billion	1.97 Billion	-	-	-
Intangible Assets	3.29 Billion	1.3 Billion	1.3 Billion	3.83 Billion	4.04 Billion	3.98 Billion
Long-Term Investments	610.8 Million	832 Million	832 Million	556.4 Million	554.7 Million	535.3 Million
Tax Assets	239.8 Million	233.3 Million	233.3 Million	150.9 Million	159.1 Million	151.8 Million
Other Non Current Assets	664.4 Million	399 Million	399 Million	614 Million	635.3 Million	631.5 Million
Other Assets	-	-	-	-	-	-
Total Liabilities	5.64 Billion	5.53 Billion	5.53 Billion	5.74 Billion	5.84 Billion	5.73 Billion
Total Current Liabilities	2.31 Billion	2.35 Billion	2.35 Billion	2.66 Billion	2.42 Billion	2.14 Billion
Account Payables	944.6 Million	1.03 Billion	561.7 Million	999.5 Million	997.5 Million	932.9 Million
Tax Payables	26.5 Million	31.1 Million	31.1 Million	21.2 Million	21.9 Million	46.3 Million
Short Term Debt	312.1 Million	308.9 Million	319.8 Million	592.8 Million	424.7 Million	208 Million
Deferred Revenue	946.9 Million	911.7 Million	911.7 Million	906.9 Million	932 Million	907.7 Million
Other Current Liabilities	107.2 Million	102.5 Million	565.2 Million	170.3 Million	70.1 Million	94.7 Million
Total Non Current Liabilities	3.33 Billion	3.17 Billion	3.17 Billion	3.07 Billion	3.42 Billion	3.59 Billion
Long-Term Debt	2.96 Billion	2.34 Billion	2.34 Billion	2.61 Billion	2.94 Billion	3.11 Billion
Deferred Revenue Non Current	-1.00	99.8 Million	99.8 Million	121 Million	118.9 Million	115.4 Million
Deferred Tax Liabilities Non Current	-	-	-	-	-	-
Other Non Current Liabilities	337.6 Million	693.6 Million	693.6 Million	260.7 Million	287.3 Million	290.9 Million
Other Liabilities	1.00	-	-	-	-	-
Total Equity	4.4 Billion	4.3 Billion	4.3 Billion	4.72 Billion	4.71 Billion	4.58 Billion
Stock Holders Equity	4.32 Billion	4.22 Billion	4.22 Billion	4.64 Billion	4.63 Billion	4.49 Billion
Common Stock	2.27 Billion	2.25 Billion	2.25 Billion	2.25 Billion	2.25 Billion	2.24 Billion
Retained Earnings	1.8 Billion	1.76 Billion	1.76 Billion	2.21 Billion	2.18 Billion	2.1 Billion
Accumulated other comprehensive income	181.3 Million	154 Million	154 Million	118.4 Million	137.9 Million	104.8 Million
Common Stock Equity	4.32 Billion	4.22 Billion	4.22 Billion	4.64 Billion	4.63 Billion	4.49 Billion
Capital Lease Obligation	314.1 Million	496.7 Million	496.7 Million	456.9 Million	446 Million	427.4 Million
Total Investments	610.8 Million	832 Million	832 Million	556.4 Million	554.7 Million	535.29 Million
Total Debt	3.27 Billion	3.14 Billion	3.15 Billion	3.2 Billion	3.36 Billion	3.31 Billion
Net Debt	3.12 Billion	2.98 Billion	2.99 Billion	3.08 Billion	3.18 Billion	3.16 Billion

Balance Sheet Charts

Yuancheng Environment Co., Ltd.

603388

Full Analysis

Annual Balance Sheets
HORIBA, Ltd.

HRIBF

Full Analysis

Annual Balance Sheets
Freeman Gold Corp.

FMAN

Full Analysis

Annual Balance Sheets
Sun Pharma Advanced Research Company Limited

SPARC

Full Analysis

Annual Balance Sheets
Navidea Biopharmaceuticals, Inc.

NAVB

Full Analysis

Annual Balance Sheets
Kamdhenu Limited

KAMDHENU

Full Analysis

Annual Balance Sheets

Global Stocks Search

CAE Inc. (CAE.TO)

Annual Balance Sheets

Balance Sheet Charts

Yuancheng Environment Co., Ltd.

HORIBA, Ltd.

Freeman Gold Corp.

Sun Pharma Advanced Research Company Limited

Navidea Biopharmaceuticals, Inc.

Kamdhenu Limited